DE69809733D1 - Synthese von acridinderivaten als inhibitoren von multipler medikamentenresistenz - Google Patents

Synthese von acridinderivaten als inhibitoren von multipler medikamentenresistenz

Info

Publication number
DE69809733D1
DE69809733D1 DE69809733T DE69809733T DE69809733D1 DE 69809733 D1 DE69809733 D1 DE 69809733D1 DE 69809733 T DE69809733 T DE 69809733T DE 69809733 T DE69809733 T DE 69809733T DE 69809733 D1 DE69809733 D1 DE 69809733D1
Authority
DE
Germany
Prior art keywords
synthesis
inhibitors
acridine derivatives
multiple medicine
medicine resistance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69809733T
Other languages
English (en)
Other versions
DE69809733T2 (de
Inventor
Jude Sharp
J Mader
Calum Strachan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of DE69809733D1 publication Critical patent/DE69809733D1/de
Publication of DE69809733T2 publication Critical patent/DE69809733T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/06—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Peptides Or Proteins (AREA)
DE69809733T 1997-05-23 1998-05-22 Synthese von acridinderivaten als inhibitoren von multipler medikamentenresistenz Expired - Lifetime DE69809733T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9710612.4A GB9710612D0 (en) 1997-05-23 1997-05-23 Synthesis of acridine derivatives
PCT/EP1998/002991 WO1998052923A1 (en) 1997-05-23 1998-05-22 Synthesis of acridine derivative multidrug-resistant inhibitors

Publications (2)

Publication Number Publication Date
DE69809733D1 true DE69809733D1 (de) 2003-01-09
DE69809733T2 DE69809733T2 (de) 2003-09-18

Family

ID=10812906

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69809733T Expired - Lifetime DE69809733T2 (de) 1997-05-23 1998-05-22 Synthese von acridinderivaten als inhibitoren von multipler medikamentenresistenz

Country Status (19)

Country Link
US (1) US6248891B1 (de)
EP (1) EP0983246B1 (de)
JP (1) JP4390861B2 (de)
KR (1) KR100536155B1 (de)
CN (1) CN1178918C (de)
AT (1) ATE228506T1 (de)
AU (1) AU744402B2 (de)
BR (1) BR9809143A (de)
CA (1) CA2289492C (de)
DE (1) DE69809733T2 (de)
DK (1) DK0983246T3 (de)
ES (1) ES2187984T3 (de)
GB (1) GB9710612D0 (de)
HK (1) HK1023995A1 (de)
HU (1) HUP0002083A3 (de)
IL (1) IL132593A (de)
PL (1) PL190109B1 (de)
PT (1) PT983246E (de)
WO (1) WO1998052923A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9708805D0 (en) 1997-05-01 1997-06-25 Smithkline Beecham Plc Compounds
GB9810876D0 (en) 1998-05-20 1998-07-22 Smithkline Beecham Plc Compounds
ID28385A (id) 1998-10-08 2001-05-17 Smithkline Beecham Plc Turunan-turunan tetrahidrobenzazepina yang berguna sebagai modulator reseptor d3 dopamina (bahan antipsikotik)
EP1749540B1 (de) * 1999-05-17 2010-10-13 Cancer Research Ventures Limited Zubereitungen zur Erhöhung der Bioverfügbarkeit von oral verabreichten pharmazeutischen Verbindungen
SI21507A (sl) 2003-05-16 2004-12-31 LEK farmacevtska dru�ba d.d. Postopek za pripravo spojin z ace inhibitornim delovanjem
US7829578B1 (en) 2005-12-12 2010-11-09 Oregon Health & Science University Aromatic ketones and uses thereof
US8592447B2 (en) * 2006-11-13 2013-11-26 Oregon Health & Science University Acridone compounds
US8598354B2 (en) 2008-12-05 2013-12-03 University Of South Florida Compounds having antiparasitic or anti-infectious activity
CA3093985A1 (en) * 2018-03-21 2019-09-26 Izumi Technology, Llc Deuterated analogs of elacridar

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ283038B6 (cs) * 1991-01-11 1997-12-17 Laboratoires Glaxo Sa Akridinové deriváty, způsob výroby a farmaceutické prostředky s jejich obsahem
BR9509251A (pt) * 1994-10-05 1997-10-21 Glaxo Wellcome Inc Composição farmacêutica processo de reverte reduzir ou inibir a resistência a multidrogas ou de restaurar a sensibilidade de um tumor e artigo manufaturado

Also Published As

Publication number Publication date
IL132593A (en) 2004-07-25
CA2289492A1 (en) 1998-11-26
EP0983246B1 (de) 2002-11-27
US6248891B1 (en) 2001-06-19
CN1255918A (zh) 2000-06-07
HK1023995A1 (en) 2000-09-29
CA2289492C (en) 2009-03-24
JP2002502371A (ja) 2002-01-22
EP0983246A1 (de) 2000-03-08
HUP0002083A2 (hu) 2001-04-28
AU744402B2 (en) 2002-02-21
IL132593A0 (en) 2001-03-19
PT983246E (pt) 2003-04-30
DE69809733T2 (de) 2003-09-18
BR9809143A (pt) 2000-08-01
KR20010012817A (ko) 2001-02-26
DK0983246T3 (da) 2003-03-24
PL336937A1 (en) 2000-07-17
PL190109B1 (pl) 2005-10-31
KR100536155B1 (ko) 2005-12-14
AU8434498A (en) 1998-12-11
ATE228506T1 (de) 2002-12-15
GB9710612D0 (en) 1997-07-16
HUP0002083A3 (en) 2002-03-28
WO1998052923A1 (en) 1998-11-26
CN1178918C (zh) 2004-12-08
JP4390861B2 (ja) 2009-12-24
ES2187984T3 (es) 2003-06-16

Similar Documents

Publication Publication Date Title
DE60004060D1 (de) Eletrolytische synthese von peressigsäure
ATE323678T1 (de) Tri-aryl-säurederivate als ppar rezeptor liganden
NO971684L (no) Nye benzoxazoler
MXPA03011681A (es) Uso de inhibidores de epoxido hidrolasa soluble, para tratar enfermedades relacionadas con la enfermedad cardiovascular.
DE69912581D1 (de) Biarylessigsäure-derivate und ihre verwendung als cox-2 inhibitoren
ATE311363T1 (de) Sulfohydroxamsäure and sulfohydroxamate und ihre verwendung als mek-inhibitoren
DE69426956T2 (de) Nachweis von Mycobakterien durch Nukleinsäure-Multiplexamplifizierung
BR9806752A (pt) Ftalazinonas.
DE69705829D1 (de) Meta-substituierte phenylsulphonamidderivate
DE59810922D1 (de) 4-heteroaryl-tetrahydrochinoline und ihre verwendung als inhibitoren des cholesterin-ester-transfer-proteins (ctep)
DE69809733T2 (de) Synthese von acridinderivaten als inhibitoren von multipler medikamentenresistenz
BR0015836A (pt) Cristal de 4-carboxiamino-2-etil-1,2,3,4-tetra-hidroquinolina como inibidor de cetp
BR0014990A (pt) Derivados de tetrahidrotiopirano ranftalazinona como inibidores de pde4
DE69702182D1 (de) Alkylierte styrole als prodrugs zu cox-2-inhibitoren
DK1404642T3 (da) Fremgangsmåde til fremstillimg af 7-amino-syn-3,5-dihydroxyheptansyrederivater, mellemprodukter derfor og fremgangsmåder til deres fremstilling
ATE250584T1 (de) Synthese von 5- oder 8-bromoisoquinolin derivaten
DE69703791T2 (de) Diphenylstibene als prodrugs zu cox-2-inhibitoren
TR200400907T4 (tr) Beta D 5-Tiyoksiloz türevleri, bunları hazırlama yöntemi ve bunların terapötik kullanımları
DE59803066D1 (de) Substituierte benzyloxyimino-verbindungen
BR0010488A (pt) Tienocicloalqu(en)ilamino-1,3,5-triazinas substituìdas
ATE286892T1 (de) Hydroxam- und carbonsäurederivate mit mmp- und tnf-hemmender aktivität
RS50861B (sr) 1,3-dioksolani kao sredstva protiv kašlja
IT1260506B (it) Processo per la preparazione di eseretolo
YU46441B (sh) Postupak za dobijanje 8{-/4-(2-pirimidinil)-1-piperazinil/butil}-8-aza-1-spiro/4,5/-dekan-7,9-diona
FI931938A0 (fi) Mellanprodukter vid framstaellning av 4,5-difluorantranilinsyra

Legal Events

Date Code Title Description
8364 No opposition during term of opposition